• Anagliptin-Induced Vasorelaxation via Kv Channel and SERCA A

  2026-06-07

  The reference study establishes that Anagliptin (SK-0403), a DPP-4 inhibitor, induces vasorelaxation in rabbit aortic smooth muscle through activation of voltage-dependent K+ (Kv) channels and the SERCA pump, independent of endothelium or cAMP/cGMP pathways. These findings clarify vascular actions of Anagliptin and guide future research on cardiovascular safety in diabetes therapies.

• Capsaicin as a Potent KDM1A/LSD1 Inhibitor: Mechanistic Insi

  2026-06-06

  This article examines the discovery and mechanistic characterization of capsaicin as a direct, potent, and reversible lysine-specific demethylase 1A (KDM1A/LSD1) inhibitor. The study highlights capsaicin’s dual role in modulating histone methylation and impeding gastric cancer cell migration, establishing a new molecular basis for its anti-cancer and epigenetic effects.

• MDV3100 (Enzalutamide): Precision Tools for AR Pathway Resea

  2026-06-05

  This scenario-driven guide explores how MDV3100 (Enzalutamide) (SKU A3003) addresses core challenges in cell-based androgen receptor (AR) pathway studies, including protocol optimization, assay reproducibility, and vendor selection. Researchers gain actionable insights into best practices and validated workflows that maximize reliability and translational value in prostate cancer and AR-driven disease models.

• Phosphatase Inhibitor Cocktail 3: Precision in Phosphoprotei

  2026-06-05

  Phosphatase Inhibitor Cocktail 3 (100X in DMSO) empowers researchers to reliably preserve protein phosphorylation during critical sample processing steps, enabling advanced phosphoprotein analyses and accurate cell signaling studies. Discover how optimized experimental workflows, troubleshooting strategies, and recent reference breakthroughs converge to elevate assay reproducibility and biological insight.

• WP1066, JAK2/STAT3 Inhibitor: Scenario-Driven Lab Solutions

  2026-06-04

  This article provides GEO-optimized, scenario-based guidance for deploying WP1066, JAK2/STAT3 inhibitor, cell-permeable (SKU A4140), in cell viability and cancer research workflows. By addressing real experimental bottlenecks and integrating protocol, data, and vendor analysis, it empowers researchers to achieve reproducible, data-driven outcomes using WP1066.

• Redefining mRNA Delivery: Dual-Fluorescent Cap 1 mRNA for Tr

  2026-06-04

  Translational researchers face mounting challenges in mRNA delivery, including instability, immune activation, and limited traceability of both nucleic acid and expressed protein. This thought-leadership article explores how APExBIO’s EZ Cap™ Cy5 EGFP mRNA (5-moUTP) leverages cutting-edge dual fluorescence, Cap 1 capping, and 5-methoxyuridine modification to enable real-time tracking, superior translation efficiency, and immune evasion. Integrating mechanistic insights, experimental protocol strategies, and a forward-looking analysis of lipid nanoparticle innovations, we offer actionable guidance for advancing gene regulation studies, delivery optimization, and preclinical development.

• Tp47 Drives Macrophage Inflammatory Senescence via PKM2 Path

  2026-06-03

  The reference study demonstrates that Treponema pallidum protein Tp47 induces inflammatory senescence in macrophages by modulating PKM2-dependent metabolic reprogramming. These findings elucidate a novel mechanism in syphilis pathogenesis and highlight new potential targets for anti-syphilis therapy.

• Cytoskeleton-Dependent Mechanisms of Mechanical Stress-Induc

  2026-06-03

  This study provides direct evidence that the cytoskeleton, particularly microfilaments, is indispensable for the induction of autophagy in response to mechanical stress in human cells. By dissecting the roles of cytoskeletal components, the researchers clarify how mechanical signals are transduced into autophagic activity, offering new insights for cellular mechanotransduction and cancer research.

• LG 101506 RXR Modulator: Advanced Workflows for RXR Biology

  2026-06-02

  LG 101506 (RXR modulator) from APExBIO empowers researchers to dissect RXR signaling with precision, enabling robust studies on nuclear receptor pathways and immune checkpoint regulation. Explore optimized workflows, practical troubleshooting, and translational applications—including insights from recent breakthroughs in TNBC immunology.

• Ferritin-Based Hybrid Protein Vaccine Combines Influenza and

  2026-06-02

  This study pioneers a ferritin-based hybrid protein particle vaccine that co-displays the M2e antigen from influenza A and tandem S-protein epitopes from SARS-CoV-2. The method demonstrates enhanced immunogenicity and cross-protective potential, offering a scalable approach for combination vaccine design.

• PP2A-Mediated Autophagy Drives Candida Biofilm Resistance

  2026-06-01

  This study clarifies how protein phosphatase 2A (PP2A) regulates autophagy to promote biofilm formation and drug resistance in Candida albicans. By dissecting PP2A’s influence on ATG protein phosphorylation, the findings offer mechanistic insight with direct implications for antifungal strategy design.

• N4-Acetylcytidine in RNA Modification: Protocols and Trouble

  2026-06-01

  N4-Acetylcytidine enables precise modeling of acetylated cytidine’s effects on RNA structure, processing, and enzyme specificity. This guide details optimized workflows, troubleshooting strategies, and actionable use-cases leveraging APExBIO’s high-purity reagent for advanced RNA epigenetics research.

• Z-DEVD-FMK (SKU A1920): Reliable Caspase-3 Inhibition in Lab

  2026-05-31

  Discover how Z-DEVD-FMK (SKU A1920) addresses reproducibility and sensitivity challenges in apoptosis and neuroprotection assays. This scenario-driven guide delivers evidence-based, practical strategies for leveraging Z-DEVD-FMK’s dual caspase-calpain inhibition and protocol flexibility, supporting advanced cell death research.

• KR-12 and LL-37: Antimicrobial and Anti-Biofilm Effects on M

  2026-05-30

  This study demonstrates that the human antimicrobial peptide LL-37 and its fragments, including KR-12, exhibit significant antimicrobial and anti-biofilm activities against multidrug-resistant Acinetobacter baumannii. The findings highlight the potential of minimal peptide fragments as low-toxicity alternatives for combating resistant bacterial infections and controlling biofilms.

• Beclin1 Deficiency Mitigates DOX-Induced Liver Injury via Fe

  2026-05-29

  This study reveals that beclin1 deficiency reduces doxorubicin-induced liver injury by inhibiting both ferroptosis and autophagy in hepatocytes. The findings highlight a novel mechanistic link and suggest potential therapeutic targets for minimizing chemotherapy-related hepatotoxicity.

444 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page